Transient receptor potential (TRP) channels are expressed throughout the central nervous system and have a unique ability to detect a wide range of stimuli including changes in voltage, temperature, pH, lipid environment, small molecule agonists, and mechanical stress. While it is known that TRP channels contain the same six transmembrane helix (S1-S6), tetrameric architecture as voltage-gated channels, the degree to which functional and structural analogies are relevant remains poorly understood. This thesis describes a multidisciplinary approach toward understanding the structure and function of TRP channel transmembrane domains by focusing on the S1-S4 transmembrane helices of the TRPV1. This focus is inspired by the voltage-sensor domain (VSD) of the S1-S4 helices of voltage-gated channels, for which a range of studies show functional and structural independence. While some TRP channels are voltage-sensitive, their S4 helix does not contain the positive string of amino acids of canonical VSDs. However, the S1-S4 helices are functionally significant as the binding site of small molecule ligands in both TRPV1 and TRPM8 (for capsaicin and menthol, respectively). The question of TRP channel transmembrane domain modularity is addressed in this thesis by expression and purification trials as well as radioligand-binding assays. It is demonstrated that the S1-S4 and S1-S6 helices of TRPV1 can be properly inserted, overexpressed, and show signs of stability upon detergent-extraction from Saccharomyces cerevisiae membranes. However the TRPV1 S1-S4 and S1-S6 helices do not show wildtype (WT)-like binding in [³H]-RTX binding assays. These results indicate that the TRPV1 transmembrane domains are likely structural but not functional domains. The S. cerevisiae expression system remained promising for the overexpression of TRP transmembrane domains as well as the production of functional, though not stable upon detergent-extraction, WT TRPV1. This WT TRPV1 was subsequently found to functionally bind both RTX, used in ligand binding assays, as well as the double-knot toxin (DkTx), targeted to the pore domain (the S5-S6 helices). An effect of DkTx on RTX binding affinity demonstrates an allosteric interaction indicative of a possible tighter packing between the two transmembrane domains than is seen in voltage-gated channels containing the canonical VSD. Computational approaches additionally allowed for the investigation of the intramembrane capsaicin binding site in the TRPV1 S1-S4 helices, crucial to the initial motivations of this study. While the literature locates the capsaicin binding site to the TRPV1 S1-S4 helices, a `binding pocket' has yet to be defined, with regards to the orientation of bound capsaicin and its access route to the site via the bilayer. Using molecular dynamics (MD) simulations the preferred location of capsaicin within the bilayer is defined, as well as the elucidiation of capsaicin flip-flop between bilayer leaflets as a key event prior to TRPV1 binding. A transient binding was also observed between a homology model of the TRPV1 S1-S4 helices and capsaicin, possibly encouraging the idea that the S1-S4 helices still contain a partial binding site, though of too low affinity to be observed in the binding experiments performed here.

This thesis describes the development of a novel approach for prediction of the three-dimensional structure of transmembrane regions of membrane proteins directly from amino acid sequence and basic transmembrane region topology. The development rationale employed involved a knowledge-based approach. Based on determined membrane protein structures, 20x20 association matrices were generated to summarise the distance associations between amino acid side chains on different alpha helical transmembrane regions of membrane proteins. Using these association matrices, combined with a knowledge-based scale for propensity for residue orientation in transmembrane segments (kPROT) (Pilpel et al., 1999), the software predicts the optimal orientations and associations of transmembrane regions and generates a 3D structural model of a gi ven membrane protein, based on the amino acid sequence composition of its transmembrane regions. During the development, several structural and biostatistical analyses of determined membrane protein structures were undertaken with the aim of ensuring a consistent and reliable association matrix upon which to base the predictions. Evaluation of the model structures obtained for the protein sequences of a dataset of 17 membrane proteins of detennined structure based on cross-validated leave-one-out testing revealed generally high accuracy of prediction, with over 80% of associations between transmembrane regions being correctly predicted. These results provide a promising basis for future development and refinement of the algorithm, and to this end, work is underway using evolutionary computing approaches. As it stands, the approach gives scope for significant immediate benefit to researchers as a valuable starting point in the prediction of structure for membrane proteins of hitherto unknown structure.

Anaplasma phagocytophilum and A. marginale are the etiologic agents of human granulocytic anaplasmosis and bovine anaplasmosis, respectively. Both diseases can be severe, even fatal, and protective vaccines for each are lacking. We recently identified A. phagocytophilum outer membrane protein A (ApOmpA) as being critical for cellular invasion and is expressed during infection of mammalian but not tick cells. Disrupting ApOmpA-host cell interactions significantly inhibits A. phagocytophilum entry into host cells. ApOmpA and its A. marginale ortholog, AM854 (A. marginale OmpA; AmOmpA) exhibit 44% amino acid identity. The ApOmpA invasin domain is highly conserved between both proteins. In this study, we investigated the differential expression of AmOmpA in mammalian versus tick cell lines; the serological cross-reactivity between AmOmpA and ApOmpA; the potential role of AmOmpA in mediating interactions with mammalian host cells; and if inhibiting the AmOmpA-host cell interaction impairs A. marginale cellular invasion. AmOmpA is expressed throughout infection of mammalian, but not tick cells. Sera from A. marginale infected cows recognized both AmOmpA and ApOmpA. Sera from cows immunized with an A. marginale OM complex that conferred protection also recognized both proteins. Thus, ApOmpA and AmOmpA share cross-reactive B-cell epitopes. To determine if AmOmpA plays a role in promoting A. marginale infection, we assessed the abilities of recombinant AmOmpA to competitively inhibit infection of mammalian host cells. To examine the cross-reactive properties of OmpA, we showed that preincubation of host cells with GST-ApOmpA and pretreatment of A. marginale with anti-GST-ApOmpA significantly inhibit A. marginale infection of host cells; and that pretreatment of A. phagocytophilum with serum from cows immunized with an A. marginale OM complex reduces its infection of host cells. These studies advance understanding of conservation of OmpA-mediated cellular invasion between Anaplasma species and highlight the potential of OmpA as a vaccinogen that could offer protection against human and veterinary anaplasmoses.

Protozoan parasites of the genus Plasmodium are the causative agent of malaria. The most severe form of human malaria is caused by P. falciparum, responsible for approximately three quarters of a million deaths each year. One major problem in the treatment of malaria is resistance to existing chemotherapies. Consequently, there is an urgent need to identify and validate novel drug targets. A possible recently identified drug target is the PfNitA protein of P. falciparum which contains orthologues in other Plasmodium species but is absent from humans. The gene is annotated as a putative formate-nitrite transporter and orthologues are found in a range of prokaryotes as well as the lower eukaryotes algae and fungi. To determine the biological function of the protein, pfnita was expressed in Escherichia coli strains lacking the endogenous formate and nitrite transporters. In order to analyse the essentiality of the gene a reverse genetics approach was taken and the data discussed. Results indicate that the PfNitA protein is located in the plasma membrane and digestive vacuole of intraerythrocytic parasites suggesting a role in the uptake or excretion of metabolites. A second complexity with regard to treatment is the lack of a vaccine. A problem in crating a vaccine is antigenic variation. The PIR family of proteins contain a so-called hypervariable domain that has led to the suggestion that the family may play a role in antigenic variation. The objective of the work carried out in this thesis was to investigate the topology and structure of the PcCir2 protein of Plasmodium chabaudi, using E. coli as the expression host. The topology of Cir2 has been examined by means of reporter fusions and overexpression/purification studies undertaken towards crystallisation. As the PcCir2 amino acid sequence does not show significant homology to other proteins, structural data may provide insights into potential functional or binding domains.

La protéine humaine hERG (human ether-à-go-go related gene) s’associe en homo-tétramère pour former le canal potassique voltage-dépendant Kv11.1. C’est un acteur majeur de la repolarisation du potentiel d’action cardiaque par sa capacité à externaliser le potassium du cardiomyocyte. L’altération de sa fonction induit le syndrome du QT long à l’origine d’arythmies cardiaques et pouvant conduire à un arrêt du cœur. Ce syndrome parfois génétique provient le plus souvent d’une inhibition pharmacologique. De nombreux médicaments ont montré leur capacité à inhiber hERG en se fixant dans la lumière du canal. L’étude des interactions moléculaires entre hERG et médicaments intéresse les scientifiques depuis de nombreuses années. Très récemment, la première structure atomique de hERG à l’état ouvert par cryo-microscopie électronique a permis une avancée majeure dans la compréhension de l’agencement du pore du canal. De nombreuses questions restent malgré tout non résolues concernant les mécanismes de liaison des ligands. Plus encore, le développement d’approches biophysiques à partir de canal purifié permettraient de caractériser et d’anticiper des interactions avec les médicaments. Dans cette perspective, nous avons testé plusieurs stratégies pour obtenir le canal hERG purifié dans une forme stable, homogène et fonctionnelle. Notre étude est basée sur une construction simplifiée et chimérique du canal hERG, la version hERG(S1-coil). Chaque étape permettant la production et la purification d’une protéine membranaire a été optimisée en testant différentes techniques proposées par la littérature. Nous avons comparé les rendements d’expression du canal dans différents systèmes recombinants procaryotes ou eucaryotes. La quantité de protéine totale et le pourcentage de protéine fonctionnelle dans les membranes ont été étudiés. Dans un deuxième temps, le canal a été solubilisé puis purifié. Nous avons comparé les rendements de solubilisation et la stabilité protéique en fonction du type de détergent. En parallèle, nous avons mis au point des moyens techniques pour évaluer la fonction du canal au fur et à mesure du processus de production et purification. Le canal hERG(S1-coil) tétramérique et fonctionnel a finalement été identifié dans la fraction purifiée. Cependant, des optimisations sont encore à apporter pour conserver l’agencement tétramérique et empêcher l’agrégation au cours du temps avant de pouvoir envisager des études biophysiques et structurales. A terme, ces travaux pourraient profiter à la production et à la purification d’autres protéines membranaires oligomériques. / The human protein hERG (human ether-à-go-go related gene) assembles as homo-tetramer to form the voltage-gated potassium channel Kv11.1. This channel is involved in repolarization of the cardiac action potential by regulating the potassium release from cardiomyocytes. hERG malfunction was found to cause long QT syndrome, a disorder that predisposes affected patients to arrhythmias and sudden death. This can be due to congenital mutation in the hERG gene and, most frequently, it is caused by pharmacological agents. Several drugs are known to block the channel ion pathway, resulting in off-target inhibition of hERG. Consequently, understanding the molecular basis of drug binding to hERG has become a high priority. The recent determination of a near-atomic resolution structure of the opened channel, using cryo-electron microscopy, provides insights into how this channel work. But several questions are still unanswered to understand the mechanisms of hERG function and drug binding. Moreover, new biophysical protocols with the purified hERG channel would help scientists and industries to anticipate drug side effects. In this context, we investigated strategies to purify a stable, homogenous and functional hERG channel. Our study was based on a shorter and chimeric hERG channel, the hERG(S1-coil) version. We optimized each step from production to purification of membrane proteins by testing experimental protocols found in the literature. In this thesis project, we first compared production rates of the channel in several prokaryote and eukaryotes recombinant systems. Total protein produced and the percent of functional channel were investigated in membranes from each recombinant system. Then, the channel was extracted from membranes before purification. Solubilizing rates and channel stability were compared depending on detergents. In another hand, we also developed protocols to investigate the channel stability and function along production and purification. A tetrameric and functional channel was finally purified and identified by this strategy. More work however is still needed to improve channel homogeneity and stability before to be suitable for biophysical and structural studies. In the future, this work could also help investigations in production and purification of other oligomeric membrane proteins.

O gene AGT1 do locus mal1g, do sistema de transporte de maltose de S. cerevisiae, codifica uma proteína de 67 kDa, que tem 75% de similaridade e 58% de identidade com o transportador de maltose do locus MAL1. Sua expressão é ativada por genes reguladores constitutivos do sistema MAL, e é reprimida pela glicose. A cepa AP68-7A carrega o gene AGT1, e possivelmente o gene transportador MAL31, e transporta trealose ao final da primeira fase de crescimento anaeróbico. SDS-PAGE comparando proteínas de membranas de células reprimidas pela glicose (taxa de transporte <0,5 U/mg), com aquelas de células induzidas por α-metilglicosídeo (taxa de transporte de ~35 U/mg), verificou-se 2 bandas (PMs 57 e 66 kDa) exclusivas em membranas de células induzidas. As 2 bandas foram isoladas por três métodos diferentes (cromatografia de troca iônica, lavagens da membrana com tampão de alta força iônica e cromatografia de afinidade) e testadas para ligação de 14C-trealose. A ligação foi enriquecida ~3 X após a cromatografia de troca iônica. O transporte de trealose na cepa AP77-4C (que não tem nenhum dos genes transportadores dos loci MAL) foi recuperado após sua transformação com plasmídeo YEp366-AGT1. De membranas plasmáticas destas células (transporte de trealose ~25 U/mg) foram isoladas por cromatografia de afinidade, 2 bandas cujos PMs em SDS-PAGE são idênticos aos das proteínas isoladas das membranas da cepa AP68-7A. Estes resultados permitem concluir que o transportador de trealose de leveduras é codificado pelo gene AGT1. / The AGT1 gene presente in the mal1g locus from S. cerevisiae maltose transport system encodes a 67 kDa protein which shares 75% similarity and 58% identity with the maltose transporter protein encoded in MAL6 locus. The expression of this gene is regulatory genes from MAL system and is repressed by glucose. The strain AP68-7A which harbors the AGT1 gene and probably the MAL31 transporter gene, expresses trehalose transport activity at the end of first anaerobic growth. The comparison from the SDS-PAGE of membrane proteins from glucose repressed cells (trehalose transport activity of <0.5 U/mg), and α-methylglucoside induced cells (trehalose transport activity of ~35 U/mg), revealed 2 bands (Mr 57 and 66 kDa) present only in the induced cells membranes. Those bands were isolated by 3 different methods (ionic exchange chromatography, high strength ionic washes and affinity chromatography, and tested for 14C-trehalose binding. Both bands bind trehalose and this activity was enriched about 3 times after the ionic exchange chromatography. The trehalose transport activity was recovered by strain AP77-4C, (which does not harbor any MAL transporter gene) after its transformation with a plasmid containing the AGT1 gene. From the membranes of these cells (trehalose transport activity of ~25 U/mg) 2 bands were isolated by affinity chromatography with similar Mrs to those isolated from AP68-7A strain. The results permit to conclude that the AGT1 gene encodes the yeast trehalose transporter.

O sorotipo O125ac:H6 compreende amostras de Escherichia coli enteropatogênica atípicas que apresentam o padrão de adesão agregativa (AA) em células HEp-2. A construção de um banco de mutantes da amostra protótipo Ec292/84 com o transposon TnphoA gerou quatro mutantes não aderentes. O objetivo deste estudo foi a caracterização genotípica e fenotípica desses mutantes. As regiões adjacentes à inserção do TnphoA no mutante Ec2921/84::01 foram amplificadas, clonadas e seqüenciadas, revelando que a inserção do TnphoA ocorreu no gene secD, parte do sistema de secreção de proteínas do tipo 2 (SST2). O perfil de proteínas de membrana externa (OMP) dos mutantes, em comparação com a amostra selvagem, revelou a ausência de proteínas de 21 e 30 kDa nos mutantes. Um antissoro obtido contra o extrato de OMP da amostra protótipo inibiu o padrão AA e reconheceu a proteína de 30 kDa em immunoblottings com extratos de OMP. Esses dados indicam que esta proteína está envolvida no estabelecimento do padrão AA de E. coli O125ac:H6 e que essa proteína é transportada através do SST2. / The serotype O125ac:H6 comprises atypical Enteropathogenic Escherichia coli strains that express the aggregative adherence (AA) pattern to HEp-2 cells. We obtained four nonadherent mutants using TnphoA insertion in the Ec292/84 strain. The aim of this study was the genetic and phenotypic characterization of these mutants. The genetic analysis of the mutants revealed that the insertion of TnphoA ocurred in the secD gene, part of the bacterial type 2 secretion system (T2SS). The mutant outer membrane proteins (OMP) profile, in comparison to the prototype strain, demonstrated the lack of expression of proteins of 21 and 30 kDa in the mutant profile. An antiserum raised against the OMP extract of the prototype strain, in addition to inhibit the AA pattern, recognized the 30 kDa protein in immunoblotting assays with OMP extract. These data indicate this OMP is involved in the establishment of the AA pattern presented by the atypical EPEC strains of the O125ac:H6 serotype, and that this protein is transported via the T2SS.

Membrane compartmentalisation allows eukaryotic cells to perform complex processes by combining dedicated sets of proteins in the same organelle. To achieve this, the cell must first target the appropriate proteins, primarily synthesised on cytosolic ribosomes, to the correct subcellular location. Components of the secretory pathway/endomembrane system begin this journey via their signal sequence-dependent delivery to the endoplasmic reticulum (ER). These ER targeting signals are hydrophobic, and typically function whilst the protein is being synthesised, via a so-called 'co-translational' pathway. However, some hydrophobic signals can also facilitate post-translational protein targeting to the ER, or initiate regulated protein degradation in the cytosol. Tail-anchored (TA) proteins are transmembrane proteins with a single C-terminal transmembrane domain that functions as both their subcellular targeting signal and membrane anchor. Recent evidence suggests that the canonical TRC40 pathway, through which mammalian TA proteins are delivered to the ER, may not be essential in vivo. In this thesis, I provide functional evidence for the existence of an orthologous SRP-independent (SND) pathway in mammalian cells and identify roles for both the signal recognition particle (SRP)-mediated pathway and presumptive mammalian SND pathway in the biogenesis of TA proteins. I conclude that although TRC40 normally plays a role in TA protein biogenesis, it is not essential, and speculate that these alternative pathways make a significant contribution to the apparent redundancy of the TRC40 pathway in vivo. The soluble components that act upstream of TRC40 during protein biogenesis also play an important role in the recognition and selective degradation of hydrophobic membrane and secretory proteins that mislocalise to the cytosol. I now provide preliminary evidence that TRC40 appears to exhibit dual functionality, having a non-essential role in TA protein delivery, whilst also contributing to protein quality control by acting as a putative holdase. My data suggest that both TRC40 and BAG6 can influence the proteasomal degradation of a novel class of substrates, which I have termed the aberrant short secretory proteins.

Mutations in the eukaryotic integral membrane protein Cystic Fibrosis Transmembrane conductance Regulator (CFTR) cause the hereditary disease cystic fibrosis (CF). CFTR functions as an ion channel at the surface of epithelial cells and regulates the movement of chloride ions and water across the plasma membrane. CFTR is difficult to express and purify in heterologous systems due to its propensity to form insoluble aggregates and its susceptibility to degradation. Obtaining good yields of highly purified CFTR has proven problematic and contributes to our limited understanding of the structure and function of the protein. The most prevalent disease causing mutation, F508del, results in misfolded CFTR which is particularly unstable and is quickly targeted for degradation by the host system and is prevented from being trafficked to the plasma membrane. There are limited treatment options for patients with the F508del mutation and it is therefore of significant interest within CF research. New methods and assays are required to identify potential compounds which could correct the F508del mutation. This thesis investigates the use of Saccharomyces cerevisiae to express and purify codon optimised recombinant CFTR. The use of a green fluorescent protein (GFP) tag enabled quick and simple detection of CFTR in whole cells and after extraction from the plasma membrane. By optimising the culture conditions for CFTR expression and detergent solubilisation conditions, relatively high yields of full-length protein were obtained. When used as a chemical chaperone at the time of inducing CFTR expression, glycerol increased yields of full-length protein. Degradation of CFTR could be limited by inducing expression at an optimal cell density and by harvesting cells within a specific time window. CFTR was extracted by solubilisation in the mild detergent dodecyl-β-D-maltopyranoside (DDM) in the presence of up to 1 M NaCl with up to ~87% efficiency in some cases. Using a gene optimisation strategy in which additional purification tags and a yeast Kozak-like sequence were added, the human CFTR (hCFTR) protein was expressed and purified. Fluorescence microscopy revealed CFTR localisation at the periphery of yeast cells. Immunoaffinity chromatography facilitated by the GFP tag at the C terminus of CFTR produced protein of up to 95% purity. An assessment of the thermal stability of this highly purified CFTR using a fluorescent probe binding assay revealed a denaturation midpoint (Tm) of ~43 degC. The ability of this assay to determine the stability of CFTR is encouraging and there is the potential to further develop it in a high-throughput manner to identify compounds which stabilise the F508del protein and which may hold the key to developing new treatments for CF.

Made available in DSpace on 2016-04-28T20:16:24Z (GMT). No. of bitstreams: 1 2007-Catia Marques da Costa.pdf: 899456 bytes, checksum: b8d00f84cefd48cf338e385b27121da0 (MD5) Previous issue date: 2007-02-28 / Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico / Anaplasma marginale (Ricktsialles: Anaplasmataceae) is a ricketsial hemoparasite responsible for causing great economic losses in cattle from tropical and subtropical regions. The objectives of this work were to produce the recombinant membrane proteins AM254, VirB9 and VirB10 and to evaluate its possible antigenicity. The genes am254, virB9 and virB10 were submitted to various experiments and were , linked to pET47 (b) plasmid. After the certification of the recombinant plasmid (pET-47-am254, pET-47-virB9 and pET-47- virB10), it was transformed into E. coli Rosetta cells for expression. The recombinant proteins produced, were analyzed by Western blot assay where the reaction of the anti-histidin monoclonal antibody against rAM254 (47kDa), rVirB9 (31kDa) and rVirB10 (60kDa) was observed. After the confirmation of the production of recombinant proteins the indirect Enzyme-Linked Immnunosorbent Assay (ELISA) was standardized with sera previously confirmed by PCR and ELISA (rMSP1 and rMSP5). The averages of the optic densities (OD) of the positive sera were of 1.339; 1.288 and 1.240 and of the negative sera of 0.470, 0.324 and 0.414 for AM254, VirB9 and VirB10 respectively with significant difference to the level of 5% between positives and negatives for each recombinant protein. The study demonstrated that the proteins rAM 254, rVirB9 and rVirB10 of A. marginale are recognized by sera of bovines immunized by different Brazilian isolates of the ricketsia (homologous and heterologous), showing the antigenicity potential of these proteins. / Anaplasma marginale (Ricktsialles: Anaplasmataceae) ? uma riquetsia intraeritroc?tica, respons?vel por ocasionar grandes perdas econ?micas na pecu?ria bovina das regi?es tropical e sub-tropical. O objetivo desse trabalho foi produzir as prote?nas de membrana recombinantes AM254, VirB9 e VirB10 e avaliar sua poss?vel antigenicidade. Os genes am254, virB9 e virB10 foram submetidos a v?rios procedimentos experimentais at? serem ligados ao plasm?deo pET-47b(+). Ap?s a certifica??o do plasm?deo recombinante (pET-47bam254, pET-47b-virB9 e pET-47bvirB10) este foi transformado em E. coli Rosetta para express?o. As prote?nas recombinantes produzidas foram analisadas pelo ensaio Western blot onde foi observada a rea??o do anticorpo monoclonal anti-histidina contra rVirB9 (31kDa), rVirB10 (60kDa) e rAM254 (47kDa). Ap?s a confirma??o da produ??o das prote?nas recombinantes realizou-se a padroniza??o do ensaio de imunoadsor??o enzim?tica (ELISA) indireto com soros oriundos de sangue total previamente confirmados por PCR; os mesmos soros tamb?m foram testados por ELISA (rMSP1 e rMSP5). As m?dias das densidades ?pticas (DO) dos soros positivos foram de 1,339; 1,288 e 1,240 e dos soros negativos de 0,470, 0,324 e 0,414 para AM254, VirB9 e VirB10 respectivamente com diferen?a significativa ao n?vel de 5% entre positivos e negativos para cada prote?na recombinante. O estudo demonstrou que as prote?nas rAM 254, rVirB9 e rVirB10 de A. marginale s?o reconhecidas por soros de bovinos imunizados com diferentes isolados brasileiros da riqu?tsia (hom?logo e heter?logos), revelando o potencial antig?nico dessas prote?nas.